keyword
https://read.qxmd.com/read/38387332/rare-flavanone-diarylheptanoid-hybrids-from-typha-angustifolia-shows-anti-breast-cancer-activity-via-activating-tgf-%C3%AE-1-smad-signaling-pathway
#41
JOURNAL ARTICLE
Yu-Peng Li, Hu Liu, Xue-Chun Zhao, Xue-Lian Tang, Peipei Shan, Hua Zhang
Four new flavanone-diarylheptanoid hetero dimers, typhatifolins A-D (1-4), were separated from the pollen of a widely distributed medicinal plant Typha angustifolia. Structures of these rare hybrids were elucidated by detailed interpretation of spectroscopic data, and their absolute configurations were determined on the basis of Mosher's method and ECD analyses. All the four compounds showed moderate to significant cytotoxicities against a panel of tumor cell lines with IC50 values ranging from 0.67 to 12.48 μM...
February 15, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38378000/methionine-secreted-by-tumor-associated-pericytes-supports-cancer-stem-cells-in-clear-cell-renal-carcinoma
#42
JOURNAL ARTICLE
ChuanJie Zhang, ZunGuo Du, Yi Gao, Kiat Shenq Lim, WenJie Zhou, Hai Huang, HongChao He, Jun Xiao, DanFeng Xu, QingQuan Li
Here, we identify a subset of vascular pericytes, defined by expression of platelet-derived growth factor receptor beta (PDGFR-β) and G-protein-coupled receptor 91 (GPR91), that promote tumorigenesis and tyrosine kinase inhibitors (TKIs) resistance by functioning as the primary methionine source for cancer stem cells (CSCs) in clear cell renal cell carcinoma (ccRCC). Tumor-cell-derived succinate binds to GPR91 on pericyte to activate autophagy for methionine production. CSCs use methionine to create stabilizing N6-methyladenosine in ATPase-family-AAA-domain-containing 2 (ATAD2) mRNA, and the resulting ATAD2 protein complexes with SRY-box transcription factor 9 to assemble super enhancers and thereby dictate its target genes that feature prominently in CSCs...
April 2, 2024: Cell Metabolism
https://read.qxmd.com/read/38372888/establishment-and-characterization-of-ncc-dfsp5-c1-a-novel-patient-derived-dermatofibrosarcoma-protuberans-cell-line
#43
JOURNAL ARTICLE
Takuya Ono, Rei Noguchi, Julia Osaki, Taro Akiyama, Yuki Adachi, Naoki Kojima, Yu Toda, Suguru Fukushima, Yuki Yoshimatsu, Akihiko Yoshida, Akira Kawai, Tadashi Kondo
Dermatofibrosarcoma protuberans (DFSP) is the most prevalent dermal sarcoma, characterized by the presence of the fusion of the collagen type I alpha 1 (COL1A1) gene with the platelet-derived growth factor beta chain (PDGFB) gene. Although PDGF receptor inhibitor imatinib mesylate was approved for the treating patients with unresectable or metastatic DFSP, disease progression was shown in 9.2% of the patients. Therefore, developing novel therapeutic strategies is crucial for improving the prognosis of DFSP...
February 19, 2024: Human Cell
https://read.qxmd.com/read/38362893/covalent-conjugation-of-small-molecule-inhibitors-and-growth-factors-to-a-silk-fibroin-derived-bioink-to-develop-phenotypically-stable-3d-bioprinted-cartilage
#44
JOURNAL ARTICLE
Nilotpal Majumder, Chandrashish Roy, Laura Doenges, Ivan Martin, Andrea Barbero, Sourabh Ghosh
Implantation of a phenotypically stable cartilage graft could represent a viable approach for repairing osteoarthritic (OA) cartilage lesions. In the present study, we investigated the effects of modulating the bone morphogenetic protein (BMP), transforming growth factor beta (TGFβ), and interleukin-1 (IL-1) signaling cascades in human bone marrow stromal cell (hBMSC)-encapsulated silk fibroin gelatin (SF-G) bioink. The selected small molecules LDN193189, TGFβ3, and IL1 receptor antagonist (IL1Ra) are covalently conjugated to SF-G biomaterial to ensure sustained release, increased bioavailability, and printability, confirmed by ATR-FTIR, release kinetics, and rheological analyses...
February 16, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38362837/biomarker-and-pharmacodynamic-activity-of-the-transforming-growth-factor-beta-tgf%C3%AE-inhibitor-sar439459-as-monotherapy-and-in-combination-with-cemiplimab-in-a-phase-i-clinical-study-in-patients-with-advanced-solid-tumors
#45
JOURNAL ARTICLE
Debbie Robbrecht, Jean-Jacques Grob, Oliver Bechter, Matteo Simonelli, Bernard Doger, Ivan Borbath, Marcus O Butler, Tina Cheng, Patricia Martin Romano, Elvire Pons-Tostivint, Massimo Di Nicola, Giuseppe Curigliano, Min-Hee Ryu, Alejo Rodriguez-Vida, Dirk Schadendorf, Elena Garralda, Giovanni Abbadessa, Brigitte Demers, Amele Amrate, Hong Wang, Joon Sang Lee, Robert Pomponio, Rui Wang
SAR439459, a 'second-generation' human anti-transforming growth factor-beta (TGFβ) monoclonal antibody, inhibits all TGFβ isoforms and improves the antitumor activity of anti-programmed cell death protein-1 therapeutics. This study reports the pharmacodynamics (PD) and biomarker results from phase I/Ib first-in-human study of SAR439459 ± cemiplimab in patients with advanced solid tumors (NCT03192345). In dose-escalation phase (Part 1), SAR439459 was administered intravenously at increasing doses either every 2 weeks (Q2W) or every 3 weeks (Q3W) with cemiplimab IV at 3 mg/kg Q2W or 350 mg Q3W, respectively, in patients with advanced solid tumors...
February 2024: Clinical and Translational Science
https://read.qxmd.com/read/38355603/biomarkers-and-prognostic-factors-of-pd-1-pd-l1-inhibitor-based-therapy-in-patients-with-advanced-hepatocellular-carcinoma
#46
REVIEW
Nan Zhang, Xu Yang, Mingjian Piao, Ziyu Xun, Yunchao Wang, Cong Ning, Xinmu Zhang, Longhao Zhang, Yanyu Wang, Shanshan Wang, Jiashuo Chao, Zhenhui Lu, Xiaobo Yang, Hanping Wang, Haitao Zhao
Systemic therapies using programmed death-1 (PD-1) and programmed death ligand 1 (PD-L1) inhibitors have demonstrated commendable efficacy in some patients with advanced hepatocellular carcinoma (HCC); however, other individuals do not respond favorably. Hence, identifying the biomarkers, the prognostic factors, and their underlying mechanisms is crucial. In this review, we summarized the latest advancements in this field. Within the tumor microenvironment, PD-L1 expression is commonly utilized to predict response...
February 14, 2024: Biomarker Research
https://read.qxmd.com/read/38354463/network-based-drug-repositioning-of-linagliptin-as-a-potential-agent-for-uterine-fibroids-targeting-transforming-growth-factor-beta-mediated-fibrosis
#47
JOURNAL ARTICLE
Anusha Shreenidhi Bhat, Amritha Chakkittukandiyil, Santhosh Kumar Muthu, Satvik Kotha, Sudharsan Muruganandham, Kalirajan Rajagopal, Saravanan Jayaram, Ram Kothandan, Divakar Selvaraj
Uterine fibroid is the most common non-cancerous tumor with no satisfactory options for long-term pharmacological treatment. Fibroblast activation protein-α (FAP) is one of the critical enzymes that enhances the fibrosis in uterine fibroids. Through STITCH database mining, we found that dipeptidyl peptidase-4 inhibitors (DPP4i) have the potential to inhibit the activity of FAP. Both DPP4 and FAP belong to the dipeptidyl peptidase family and share a similar catalytic domain. Hence, ligands which have a binding affinity with DPP4 could also bind with FAP...
February 8, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38349124/defining-signals-that-promote-human-alveolar-type-i-differentiation
#48
JOURNAL ARTICLE
Yong Li, Y S Prakash, Qi Tan, Daniel J Tschumperlin
Alveolar type I (ATI) cells cover >95% of the lung's distal surface and facilitate gas exchange through their exceptionally thin shape. ATI cells in vivo are replenished by alveolar type II cell division and differentiation, but a detailed understanding of ATI biology has been hampered by the challenges in direct isolation of these cell due to their fragility, and incomplete understanding of the signaling interactions that promote differentiation of ATII to ATI cells. Here we explored the signals that maintain ATII versus promote ATI fates in 3D organoid cultures, and developed a human alveolar type I differentiation medium (hATIDM) suitable for generating ATI cells from either mixed distal human lung cells or purified ATII cells...
February 13, 2024: American Journal of Physiology. Lung Cellular and Molecular Physiology
https://read.qxmd.com/read/38342100/gap-junction-beta-4-accelerates-cell-cycle-progression-and-metastasis-through-met-akt-activation-in-pancreatic-cancer
#49
JOURNAL ARTICLE
Joji Muramatsu, Yohei Arihara, Makoto Yoshida, Tomohiro Kubo, Hajime Nakamura, Kazuma Ishikawa, Hiromi Fujita, Shintaro Sugita, Takumi Konno, Takashi Kojima, Yutaka Kawano, Masayoshi Kobune, Kohichi Takada
Despite continuing advances in the development of effective new therapies, including immunotherapies, the prognosis of pancreatic cancer remains extremely poor. Gap junction proteins have become attractive targets for potential cancer therapy. However, the role of gap junction beta-4 (GJB4) protein remains unexplored in pancreatic cancer. Through bioinformatic analyses we discovered pancreatic cancer tissues showed higher levels of GJB4 transcripts compared to normal pancreatic tissues and this had a negative effect on overall survival in patients that had pancreatic cancer...
February 11, 2024: Cancer Science
https://read.qxmd.com/read/38320454/vdr-regulates-mitochondrial-function-as-a-protective-mechanism-against-renal-tubular-cell-injury-in-diabetic-rats
#50
JOURNAL ARTICLE
Hong Chen, Hao Zhang, Ai-Mei Li, Yu-Ting Liu, Yan Liu, Wei Zhang, Cheng Yang, Na Song, Ming Zhan, Shikun Yang
PURPOSE: To investigate the regulatory effect and mechanism of Vitamin D receptor (VDR) on mitochondrial function in renal tubular epithelial cell under diabetic status. METHODS: The diabetic rats induced by streptozotocin (STZ) and HK-2 cells under high glocose(HG)/transforming growth factor beta (TGF-β) stimulation were used in this study. Calcitriol was administered for 24 weeks. Renal tubulointerstitial injury and some parameters of mitochondrial function including mitophagy, mitochondrial fission, mitochondrial ROS, mitochondrial membrane potential (MMP), mitochondrial ATP, Complex V activity and mitochondria-associated ER membranes (MAMs) integrity were examined...
April 2024: Redox Biology
https://read.qxmd.com/read/38313882/lagerstroemia-speciosa-pers-lythraceae-ethanolic-extract-attenuates-isoniazid-induced-oxidative-stress-and-hepatic-inflammation-in-rats
#51
JOURNAL ARTICLE
T Rohit Singh, Devaraj Ezhilarasan, Munusamy Karthick, Karthik Shree Harini
Background Drug-induced liver injury is a common cause of acute liver failure. Isoniazid (INH) is used as a first-line treatment for tuberculosis. Clinical and experimental studies have reported abnormal liver function after INH therapy. Lagerstroemia speciosa Pers., commonly known as banaba, has been traditionally used to treat various ailments including diabetes and obesity due to its antioxidant and anti-inflammatory properties. Aim To investigate the hepatoprotective effect of ethanolic banaba leaf extract (EBLE) against INH-induced hepatotoxicity in rats...
January 2024: Curēus
https://read.qxmd.com/read/38311121/hiv-coinfection-exacerbates-hbv-induced-liver-fibrogenesis-through-a-hif-1%C3%AE-and-tgf-%C3%AE-1-dependent-pathway
#52
JOURNAL ARTICLE
Min Xu, Charlotte Warner, Xiaoqiong Duan, Zhimeng Cheng, Andre J Jeyarajan, Wenting Li, Yongtao Wang, Tuo Shao, Shadi Salloum, Pei-Jer Chen, Xu Yu, Raymond T Chung, Wenyu Lin
BACKGROUND & AIMS: Persons with chronic hepatitis B virus (HBV) infection coinfected with HIV experience accelerated progression of liver fibrosis compared to those with HBV mono-infection. We hypothesize that HIV and its proteins promote HBV-induced liver fibrosis in HIV/HBV coinfected cell culture models through HIF-1α and TGF-β1 signaling. METHODS: The HBV positive supernatant, purified HBV viral particles, HIV positive supernatant, or HIV viral particles were directly incubated (or infected) with cell lines or primary cells of hepatocytes, hepatic stellate cells, and macrophages in mono or 3D spheroid coculture models...
February 2, 2024: Journal of Hepatology
https://read.qxmd.com/read/38308773/perianal-fistulizing-crohn-s-disease-current-perspectives-on-diagnosis-monitoring-and-management-with-a-focus-on-emerging-therapies
#53
REVIEW
Jalpa Devi, David H Ballard, Tina Aswani-Omprakash, Alyssa M Parian, Parakkal Deepak
Crohn's disease (CD), a chronic inflammatory bowel disorder, manifests in various phenotypes, with fistulizing perianal CD (CD-PAF) being one of its most severe phenotypes. Characterized by fistula formation and abscesses, CD-PAF impacts 17% to 34% of all CD cases and with a significantly deleterious impact on patient's quality of life, while increasing the risk for anorectal cancers. The pathogenesis involves a complex interplay of genetic, immunological and environmental factors, with cytokines such as tumor necrosis factor-alpha (TNF-α) and transforming growth factor-beta (TGF-β) playing pivotal roles...
February 2024: Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology
https://read.qxmd.com/read/38281811/macrophages-enhance-regeneration-of-lateral-line-neuromast-derived-from-interneuromast-cells-through-tgf-%C3%AE-in-zebrafish
#54
JOURNAL ARTICLE
Wei-Lin Hsu, Yu-Chi Lin, Meng-Ju Lin, Yi-Wen Wang, Shyh-Jye Lee
Macrophages play a pivotal role in the response to injury, contributing significantly to the repair and regrowth of damaged tissues. The external lateral line system in aquatic organisms offers a practical model for studying regeneration, featuring interneuromast cells connecting sensory neuromasts. Under normal conditions, these cells remain dormant, but their transformation into neuromasts occurs when overcoming inhibitory signals from Schwann cells and posterior lateral line nerves. The mechanism enabling interneuromast cells to evade inhibition by Schwann cells remains unclear...
January 28, 2024: Development, Growth & Differentiation
https://read.qxmd.com/read/38266571/dapagliflozin-attenuates-renal-fibrosis-by-suppressing-angiotensin-ii-tgf%C3%AE-signaling-in-diabetic-mice
#55
JOURNAL ARTICLE
Mingwang Jiang, Zhichen Yang, Lu Lyu, Meng Shi
AIMS: Diabetic nephropathy (DN) complicates diabetes Mellitus and intimately relates to intrarenal renin-angiotensin system (RAS) activity. Dapagliflozin, a selective inhibitor of sodium-glucose cotransporter 2 (SGLT2), has been validated to improve renal outcomes in diabetic patients from clinical research by elusive mechanisms. This study explored the presumption that the eagerness activity of intrarenal RAS in DN generated oxidative stress to promote renal fibrosis, and the process can be interrupted by dapagliflozin...
January 16, 2024: Journal of Diabetes and its Complications
https://read.qxmd.com/read/38238982/urinary-biomarkers-in-children-with-neurogenic-and-non-neurogenic-lower-urinary-tract-dysfunction-a-systematic-review-and-meta-analysis
#56
REVIEW
Cagri Akin Sekerci, Selcuk Yucel, Tufan Tarcan
AIM: The aim of this systematic review is to assess urinary biomarkers studied in children with neurogenic and non-neurogenic lower urinary tract dysfunction (LUTD). MATERIALS AND METHODS: The systematic review was conducted in accordance with the PRISMA guidelines. The screening was performed on PUBMED without any publication date limitation. Only original articles were included. Parameters related to the following topics were obtained: study design, characteristics of participants, number of participants, age, control group, types of biomarkers, measurement technique in urine, subgroup analysis, urodynamic findings, and outcome...
January 18, 2024: Neurourology and Urodynamics
https://read.qxmd.com/read/38204245/fucoxanthin-enhances-the-antifibrotic-potential-of-placenta-derived-mesenchymal-stem-cells-in-a-ccl4-induced-mouse-model-of-liver-fibrosis
#57
JOURNAL ARTICLE
Vasilii Slautin, Konstantin Konyshev, Ilya Gavrilov, Olga Beresneva, Irina Maklakova, Dmitry Grebnev
BACKGROUND: The effectiveness of fucoxanthin (Fx) in liver diseases has been reported due to its anti-inflammatory and antifibrotic effects. Mesenchymal stem cells (MSCs)-based therapy has also been proposed as a promising strategy for liver fibrosis treatment. Recent studies have shown that the co-administration of MSCs and drugs demonstrates a pronounced effect on liver fibrosis. AIM: This study aimed to determine the therapeutic potential of placenta-derived MSCs (PD-MSCs) in combination with Fx to treat liver fibrosis and evaluate their impact on the main links of liver fibrosis pathogenesis...
January 8, 2024: Current Stem Cell Research & Therapy
https://read.qxmd.com/read/38179125/elevated-secretion-of-pro-collagen-i-alpha-and-vascular-endothelial-growth-factor-as-biomarkers-of-acetabular-labrum-degeneration-and-calcification-in-hip-osteoarthritis-an-explant-study
#58
JOURNAL ARTICLE
Alexander Antoniadis, Julien Wegrzyn, Patrick Omoumi, Léa Loisay, Thomas Hügle, Jeroen Geurts
BACKGROUND: Hip osteoarthritis (OA) involves structural degeneration of different joint compartments, including femoral head cartilage, periarticular ligaments and the acetabular labrum. However, the molecular mechanisms underlying labrum degeneration in hip OA remain poorly understood. AIM: To assess secretion of putative biomarkers for OA from explanted human labrum tissues under basal and inflammatory conditions and to determine whether these could differentiate between OA and calcification status compared to fracture controls...
January 2024: Journal of Orthopaedic Translation
https://read.qxmd.com/read/38173372/dwn12088-a-prolyl-trna-synthetase-inhibitor-alleviates-hepatic-injury-in-nonalcoholic-steatohepatitis
#59
JOURNAL ARTICLE
Dong-Keon Lee, Su Ho Jo, Eun Soo Lee, Kyung Bong Ha, Na Won Park, Deok-Hoon Kong, Sang-In Park, Joon Seok Park, Choon Hee Chung
BACKGROUND: Nonalcoholic steatohepatitis (NASH) is a liver disease caused by obesity that leads to hepatic lipoapoptosis, resulting in fibrosis and cirrhosis. However, the mechanism underlying NASH is largely unknown, and there is currently no effective therapeutic agent against it. DWN12088, an agent used for treating idiopathic pulmonary fibrosis, is a selective prolyl-tRNA synthetase (PRS) inhibitor that suppresses the synthesis of collagen. However, the mechanism underlying the hepatoprotective effect of DWN12088 is not clear...
January 3, 2024: Diabetes & Metabolism Journal
https://read.qxmd.com/read/38158493/drugs-targeting-tgf-%C3%AE-notch-interaction-attenuate-hypertrophic-scar-formation-by-optic-atrophy-1-mediated-mitochondrial-fusion
#60
JOURNAL ARTICLE
Da Huo, Xin-Yu Bi, Jun-Ling Zeng, Da-Mao Dai, Xiang-Lin Dong
Hypertrophic scar (HS) formation is a cutaneous fibroproliferative disease that occurs after skin injuries and results in severe functional and esthetic disability. To date, few drugs have shown satisfactory outcomes for the treatment of HS formation. Transforming growth factor-beta (TGF-β)/Notch interaction via small mothers against decapentaplegic 3 (Smad3) could facilitate HS formation; therefore, targeting TGF-β/ Notch interaction via Smad3 is a potential therapeutic strategy to attenuate HS formation...
December 29, 2023: Molecular and Cellular Biochemistry
keyword
keyword
98679
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.